Dr. Brian Van Tine, MD

Oncology •  Male • Age 47

  10 Reviews
Dr. Van Tine

Saint Louis Office

660 S Euclid Ave Saint Louis, MO 63110

Make an Appointment

(314) 362-8376

Dr. Brian Van Tine, MD is an oncology specialist in Saint Louis, MO. He specializes in oncology and medical oncology.

At a Glance

  • Explains conditions well Patients said this doctor explains conditions well. See reviews
  • Hospital satisfaction Patients said they were highly satisfied at this doctor's hospital. See hospitals
  • Practices at top hospital Patient Safety Excellence Award™ See hospitals

Insurance Check

Search for your insurance provider

Dr. Van Tine accepts

Accepted insurance can change. Please double-check when making an appointment.

(314) 362-8376

Dr. Van Tine accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
American Republic
Anthem Blue Cross Blue Shield
Anthem Blue Cross Blue Shield PPO
Benesys
Blue Cross Blue Shield
Blue Card PPO
Cigna
Cigna HMO
Cigna PPO
LocalPlus
Open Access Plus
Commercial Insurance Company
Coventry Health Care
Golden Rule
HealthLink
HealthLink PPO
Humana
Choice Care PPO
Medicaid
Medico
Molina Healthcare
Molina
MultiPlan
MultiPlan PPO
PHCS Network PPO
UnitedHealthCare
United Healthcare

Background Check

Healthgrades does not collect malpractice claims information for Missouri
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Van Tine's experience treating your condition or procedure

Dr. Van Tine's Top Procedures and Conditions

Treatment Frequency
Osteosarcoma
very high
very high

Treatment Frequency

Dr. Van Tine treats Osteosarcoma more than 100% of his peers

Dr. Van Tine treats this condition more than 100% of his peers

Rating Includes other areas of care:

  • Ewing's Sarcoma
Soft Tissue Sarcoma
very high
very high

Treatment Frequency

Dr. Van Tine treats Soft Tissue Sarcoma more than 100% of his peers

Dr. Van Tine treats this condition more than 100% of his peers

Bone Cancer
very high
very high

Treatment Frequency

Dr. Van Tine treats Bone Cancer more than 96% of his peers

Dr. Van Tine treats this condition more than 96% of his peers

Rating Includes other areas of care:

  • Hip Cancer
  • Pelvic Cancer

Dr. Van Tine's conditions and procedures:

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Adrenal Gland Cancer
  • All Lymphoma
  • Anal and Rectal Cancer
  • Anal Disorders
  • Anemia
  • Autoimmune Diseases
  • Basal Cell Carcinoma
  • Bladder Cancer
  • Bleeding Disorders
  • Blood Disorders
  • Bone Cancer
  • Bone Disorders
  • Bone Marrow Biopsy
  • Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brain Disorders
  • Breast Cancer
  • Breast Diseases
  • Burkitt's Lymphoma
  • Cancer
  • Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
  • Central Nervous System Lymphoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Coagulation Disorders (incl. Hemophilia)
  • Colorectal Cancer
  • Esophageal Cancer
  • Esophageal Diseases
  • Gallbladder and Biliary Tract Cancer
  • Gallbladder Cancer
  • Gastrointestinal Diseases
  • Graft vs Host Disease
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Heart Tumors, Malignant
  • Hodgkin's Disease
  • Hypercoagulable State
  • Immune Thrombocytopenic Purpura (ITP)
  • Kaposi's Sarcoma
  • Kidney Cancer
  • Laryngeal Cancer
  • Larynx Conditions
  • Leukocytosis
  • Liver Cancer
  • Lung Cancer
  • Lymphoma, Large Cell, Anaplastic
  • Lymphoma, Large-Cell
  • Lymphosarcoma
  • Malignant Histiocytosis
  • Mantle Cell Lymphoma
  • Marginal Zone Lymphoma
  • Mediastinal Tumors, Malignant
  • Melanoma
  • Meningiomas
  • Merkel Cell Carcinoma
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Neuroendocrine Tumors
  • Neutropenia
  • Nodular Lymphoma
  • Non-Hodgkin's Lymphoma
  • Oral Cancer
  • Osteosarcoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pancytopenia
  • Pleura Cancer
  • Pleural Cancer
  • Primary Central Nervous System Lymphoma
  • Primary Hypercoagulable State (incl. Factor V Leiden Disease)
  • Prostate Cancer
  • Pulmonary Disease
  • Purpura
  • Reticulosarcoma
  • Retina Diseases
  • Salivary Gland Cancer
  • Secondary Malignancies
  • Sezary's Disease
  • Sickle Cell Disease
  • Skin Cancer
  • Small Intestine Cancer
  • Soft Tissue Sarcoma
  • Squamous Cell Carcinoma
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Diseases
  • Testicular Cancer
  • Thoracentesis
  • Throat Cancer (Hypopharyngeal)
  • Throat Cancer (Nasopharyngeal)
  • Throat Cancer (Oropharyngeal)
  • Thrombocytosis
  • Thyroid Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Urinary Disorders
  • Uterine Cancer
  • Uterine Diseases
  • Vaginal Cancer
  • Vascular Disease
  • Vertebral Column Tumors

Dr. Van Tine's Reviews

Likelihood to recommend Dr. Van Tine

4.2

Based on 10 reviews

5 Stars
80%
(8)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
20%
(2)

Leave a review

How likely are you to recommend
Dr. Van Tine?
(Select your rating)
Average Reported Wait Time
  • 16 – 30 minutes
Dr. Van Tine's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness

Be the first to leave a comment

How was your experience with Dr. Van Tine?

About Me

Biography

Dr. Brian Van Tine, MD is an oncology specialist in Saint Louis, MO. He specializes in oncology and medical oncology.

Specialties

  • Oncology
  • Medical Oncology

Board Certifications

  • Internal Medicine
  • Medical Oncology

Awards

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Van Tine treats patients.

Learn more

Barnes Jewish Hospital

Saint Louis, MO

75% Patient experience rating, 6% higher than the national average

72% Patient experience rating, 3% higher than the national average

  • Patient Safety Excellence Award™ (2019, 2018, 2017)